Zivo Bioscience CEO John Payne's 2023 pay falls 53% to $400K

Zivo Bioscience reports 2023 executive compensation

By ExecPay News

Published: April 26, 2024

Zivo Bioscience reported fiscal year 2023 executive compensation information on April 26, 2024.
In 2023, two executives at Zivo Bioscience received on average a compensation package of $356K, a 48% decrease compared to previous year.
Average pay of disclosed executives at Zivo Bioscience
John B. Payne, Chief Executive Officer, received $400K in total, which decreased by 53% compared to 2022. 100% of Payne's compensation, or $400K, was in salary.
Keith Marchiando, Chief Financial Officer, received a compensation package of $312K, which decreased by 40% compared to previous year. 100% of the compensation package, or $312K, was in salary.

Related executives

John Payne

Zivo Bioscience

Chief Executive Officer

Keith Marchiando

Zivo Bioscience

Chief Financial Officer

You may also like

Source: SEC filing on April 26, 2024.